Long‐term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14‐year, single‐center experience

The long‐term effects of tyrosine kinase inhibitors (TKIs), including imatinib, and surgical intervention on advanced gastrointestinal stromal tumor (GIST) were evaluated. All 379 patients had metastatic or recurrent GIST and started 400 mg/d imatinib at the Asan Medical Center in periods 1 and 2 [2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jwa Hoon, Ryu, Min‐Hee, Yoo, Changhoon, Chae, Heejung, Na, Hana, Beck, Moyoul, Kim, Beom Su, Yoo, Moon‐Won, Yook, Jeong Hwan, Kim, Byung Sik, Kim, Ki‐Hun, Kim, Chan Wook, Kang, Yoon‐Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434201/
https://www.ncbi.nlm.nih.gov/pubmed/30693663
http://dx.doi.org/10.1002/cam4.1994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434201/
https://www.ncbi.nlm.nih.gov/pubmed/30693663
http://dx.doi.org/10.1002/cam4.1994

Ejemplares similares